User profiles for Per Qvist
Per QvistAssociate Professor, Aarhus University Verified email at biomed.au.dk Cited by 9430 |
The disease modifying osteoarthritis drug (DMOAD): is it in the horizon?
P Qvist, AC Bay-Jensen, C Christiansen, EB Dam… - Pharmacological …, 2008 - Elsevier
Till date, the pharmaceutical industry has failed to bring effective and safe disease modifying
osteoarthritic drugs (DMOADs) to the millions of patients suffering from this serious and …
osteoarthritic drugs (DMOADs) to the millions of patients suffering from this serious and …
Which elements are involved in reversible and irreversible cartilage degradation in osteoarthritis?
…, BC Sondergaard, P Pastoureau, P Qvist… - Rheumatology …, 2010 - Springer
Osteoarthritis (OA) is a disease of the entire joint. Different treatment strategies for OA have
been proposed and tested clinically without the desired efficacy. One reason for the scarcity …
been proposed and tested clinically without the desired efficacy. One reason for the scarcity …
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
Major depressive disorder (MDD) is a common illness accompanied by considerable
morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide …
morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide …
[HTML][HTML] Biochemical markers of ongoing joint damage in rheumatoid arthritis-current and future applications, limitations and opportunities
…, C Christiansen, T Schubert, P Qvist… - Arthritis research & …, 2011 - Springer
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease associated with
potentially debilitating joint inflammation, as well as altered skeletal bone metabolism and co-…
potentially debilitating joint inflammation, as well as altered skeletal bone metabolism and co-…
Identification of common genetic risk variants for autism spectrum disorder
Autism spectrum disorder (ASD) is a highly heritable and heterogeneous group of
neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic variants …
neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic variants …
[HTML][HTML] Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders
…, T Nærland, M Nyegaard, D Pinto, P Qvist… - Cell, 2019 - cell.com
Genetic influences on psychiatric disorders transcend diagnostic boundaries, suggesting
substantial pleiotropy of contributing loci. However, the nature and mechanisms of these …
substantial pleiotropy of contributing loci. However, the nature and mechanisms of these …
[HTML][HTML] CtIP Mutations Cause Seckel and Jawad Syndromes
Seckel syndrome is a recessively inherited dwarfism disorder characterized by microcephaly
and a unique head profile. Genetically, it constitutes a heterogeneous condition, with …
and a unique head profile. Genetically, it constitutes a heterogeneous condition, with …
Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal …
…, S Christgau, BJ Pedersen, M Bonde, P Qvist… - Clinical …, 1998 - academic.oup.com
We have developed a two-site ELISA for measurement in serum of bone-related degradation
products derived from C-terminal telopeptides of type I collagen. The assay is based on the …
products derived from C-terminal telopeptides of type I collagen. The assay is based on the …
The genetic architecture of depression in individuals of East Asian ancestry: a genome-wide association study
…, G Pistis, D Posthuma, JA Quiroz, P Qvist… - JAMA …, 2021 - jamanetwork.com
Importance Most previous genome-wide association studies (GWAS) of depression have used
data from individuals of European descent. This limits the understanding of the underlying …
data from individuals of European descent. This limits the understanding of the underlying …
Immunoassay for quantifying type I collagen degradation products in urine evaluated
M Bonde, P Qvist, C Fledelius, BJ Riis… - Clinical …, 1994 - academic.oup.com
An enzyme-linked immunosorbent assay (ELISA) for measuring type I collagen degradation
products in urine < 3 h was evaluated. The measuring range was 0.5-10.5 mg/L with a …
products in urine < 3 h was evaluated. The measuring range was 0.5-10.5 mg/L with a …